Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Oncology

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2013.2077PMID 23982736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Senescence: a new weapon for cancer therapy.

  2012cited by this paper
• Cancer cell senescence: a new frontier in drug development.

  2012cited by this paper
• In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma

  2012cited by this paper
• Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair.

  2012cited by this paper
• Metformin and Hepatic Carcinogenesis

  2012cited by this paper
• Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.

  2012cited by this paper
• Metformin and neoplasia: implications and indications.

  2012cited by this paper
• Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• SIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model

  2011cited by this paper
• Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

  2011cited by this paper
• Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.

  2011cited by this paper
• Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

  2011cited by this paper
• Metformin: Multi-faceted protection against cancer

  2011cited by this paper
• AMPK induces vascular smooth muscle cell senescence via LKB1 dependent pathway.

  2011cited by this paper
• Pro-senescence therapy for cancer treatment

  2011cited by this paper
• The essence of senescence.

  2010cited by this paper
• SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells

  2010cited by this paper
• Therapy-induced senescence in cancer.

  2010cited by this paper
• Senescence in tumours: evidence from mice and humans

  2010cited by this paper
• Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo

  2009cited by this paper
• DEC1, a Basic Helix-Loop-Helix Transcription Factor and a Novel Target Gene of the p53 Family, Mediates p53-dependent Premature Senescence*

  2008cited by this paper
• Premature aging in mice activates a systemic metabolic response involving autophagy induction.

  2008cited by this paper
• Cellular senescence in cancer and aging.

  2007cited by this paper
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

  2007cited by this paper
• AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

  2005cited by this paper
• Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence

  2004cited by this paper
• Increased AMP:ATP Ratio and AMP-activated Protein Kinase Activity during Cellular Senescence Linked to Reduced HuR Function*

  2003cited by this paper
• Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence.

  2003cited by this paper
• Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence

  2002cited by this paper
• Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• Sir2 links chromatin silencing, metabolism, and aging.

  2000cited by this paper
• A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

  1995cited by this paper

• Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer.

  2026cites this paper
• Metformin and chloroquine enhanced the efficacy of cytarabine in acute lymphoblastic leukemia cell lines: a drug repositioning approach

  2025cites this paper
• Metformin Impairs Breast Cancer Growth through the Inhibition of PRMT6

  2025cites this paper
• PAQR4: A Critical Senescence-Related Gene Influencing Immune Evasion and Metastasis in Bladder Urothelial Carcinoma

  2025cites this paper
• Effects of Metformin on Leukemia: Biological Mechanisms, Targets, and Treatment Possibilities

  2025cites this paper
• Effects of long-term metformin intake on postoperative clinicopathological characteristics in patients with invasive lung adenocarcinoma and type 2 diabetes mellitus: A retrospective analysis

  2025cites this paper
• Urolithin A Alleviates Doxorubicin-Induced Senescence in Mesenchymal Stem Cells

  2025cites this paper
• Ubiquitination and Acetylation in Cellular Senescence: Mechanisms, Crosstalk, and Therapeutic Implications

  2025cites this paper
• Involvement of SIRT1-mediated aging in liver diseases

  2025cites this paper
• Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence.

  2025cites this paper
• Cancer prevention and interception with antidiabetic and anti-obesity drugs: current and future perspectives.

  2025cites this paper
• Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells

  2024cites this paper
• Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts

  2024cites this paper
• Biochemical and transcriptomic evaluation of a 3D lung organoid platform for pre-clinical testing of active substances targeting senescence

  2024cites this paper
• Andrographis paniculata Ethanol Extract Alleviates High Glucose-induced Senescence of Human Umbilical Vein Endothelial Cells via the Regulation of mTOR and SIRT1 Pathways

  2024cites this paper
• Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma

  2024cites this paper
• Phytol and (−)-α-bisabolol Synergistically trigger intrinsic apoptosis through redox and Ca2+ imbalance in non-small cell lung cancer

  2024cites this paper
• Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)

  2023cites this paper
• Pleiotropic Effects of Metformin in Osteoarthritis

  2023cites this paper
• Radiation-induced senescence: therapeutic opportunities

  2023cites this paper
• Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis

  2023cites this paper
• Integrated Stress Response (ISR) Pathway: Unraveling Its Role in Cellular Senescence

  2023cites this paper
• Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing

  2023cites this paper
• Antitumor activity of Metformin through p53 and Cyclin D1 in the Urothelial Cell Carcinoma

  2023cites this paper
• Ovarian Function in Patients Who Underwent Opportunistic Bilateral Salpingectomy during Hysterectomy

  2022cites this paper
• Repurposing Drugs in Small Animal Oncology

  2022cites this paper
• Metformin Induces PRODH/POX-Dependent Apoptosis in Breast Cancer Cells

  2022cites this paper
• Association of sirtuins (SIRT1-7) with lung and intestinal diseases

  2022cites this paper
• Mechanisms of cancer cell killing by metformin: a review on different cell death pathways

  2022cites this paper
• Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis

  2021cites this paper
• Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53.

  2021cites this paper
• Acidosis‐induced activation of distal nephron principal cells triggers Gdf15 secretion and adaptive proliferation of intercalated cells

  2021cites this paper
• Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population

  2021cites this paper
• The Gut Microbiome, Metformin, and Aging.

  2021cites this paper
• Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)

  2021cites this paper
• Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism

  2020cites this paper
• Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma

  2020cites this paper
• Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis

  2020cites this paper
• Benefits of Metformin in Attenuating the Hallmarks of Aging.

  2020cites this paper
• OTT_A_240252 3777..3788

  2020cites this paper
• Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer

  2020cites this paper
• Non-circadian aspects of BHLHE40 cellular function in cancer

  2020cites this paper
• The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct

  2020cites this paper
• Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells

  2020cites this paper
• Activation of LKB1 rescues 3T3-L1 adipocytes from senescence induced by Sirt1 knock-down: a pivotal role of LKB1 in cellular aging

  2020cites this paper
• Mechanisms of metformin inhibiting cancer invasion and migration.

  2020cites this paper
• Metabolism and immunity in breast cancer

  2020cites this paper
• 4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling.

  2020cites this paper
• Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer

  2019cites this paper
• Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

  2019cites this paper
• Senolytics and senostatics as adjuvant tumour therapy

  2019cites this paper
• Epigenetic Aspects of Hepatocellular Carcinoma Chemoprevention

  2019cites this paper
• 6-Bromoindirubin-3′-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes Autophagy, and Exerts Anti-aging Effects in Rodent Liver

  2019cites this paper
• The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma

  2019cites this paper
• The Potential Effect of Metformin on Cancer: An Umbrella Review

  2019influential citation
• SIRT1 in the Development and Treatment of Hepatocellular Carcinoma

  2019cites this paper
• MicroRNA‑506 regulates apoptosis in retinoblastoma cells by targeting sirtuin 1

  2019cites this paper
• Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway.

  2019cites this paper
• CMAR_A_211122 8419..8429

  2019cites this paper
• LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective

  2019cites this paper
• Repurposing drugs for the treatment of glioma

  2019cites this paper
• A Network-based Analysis of Hepatocellular Carcinoma

  2019cites this paper
• Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells

  2018cites this paper
• Band Alignment-Driven Oxidative Injury to the Skin by Anatase/Rutile Mixed-Phase Titanium Dioxide Nanoparticles Under Sunlight Exposure

  2018cites this paper
• SIRT1 and microRNAs: The role in breast, lung and prostate cancers

  2018cites this paper
• Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study123

  2018cites this paper
• p53 and metabolism: from mechanism to therapeutics

  2018cites this paper
• Metformin – the newer role of the old medicine - in cancer prevention and treatment!

  2017cites this paper
• Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts

  2017cites this paper
• Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts.

  2017cites this paper
• Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.

  2017cites this paper
• Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP‐activated protein kinase

  2017cites this paper
• Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6‐independent manner

  2017cites this paper
• AMPK: Therapeutic Target for Diabetes and Cancer Prevention.

  2017cites this paper
• Analysis of the effects of metformin administered alone or in combined treatments in colorectal cancer

  2017cites this paper
• Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib

  2017cites this paper
• Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells

  2016cites this paper
• Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression

  2016cites this paper
• Effects of Epothilone A in Combination with Metformin and Sitagliptin in HepG2 Cells

  2016cites this paper
• Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.

  2016cites this paper
• Anti-tumor activity of metformin: from metabolic and epigenetic perspectives

  2016cites this paper
• Absence of AMPKα2 accelerates cellular senescence via p16 induction in mouse embryonic fibroblasts.

  2016influential citation
• Prognostic significance of AMPK in human malignancies: A meta-analysis

  2016cites this paper
• 6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation

  2015cites this paper
• Protein Modification and Tumor Glycolysis

  2015cites this paper
• Impact of insulin resistance on hepatocellular carcinoma

  2015cites this paper
• Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment.

  2015cites this paper
• Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy.

  2015cites this paper
• Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis

  2015cites this paper
• Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions

  2015cites this paper
• Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma

  2015cites this paper
• Targeting AMPK for cancer prevention and treatment

  2015cites this paper
• Metformin as a cellular protector; a synoptic view of modern evidences

  2015cites this paper
• Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia

  2015cites this paper
• ing apoptosis via mitochondrion-mediated pathwa

  2015cites this paper
• Metformin and hepatocellular carcinoma

  2014cites this paper
• Stra13 and Sharp-1, the non-grouchy regulators of development and disease.

  2014cites this paper
• Metformin in cancer prevention and therapy.

  2014cites this paper
• Metformin and anti-cancer effects: Systematic insights into its therapeutic potential

  year unknowncites this paper
• World Journal of Diabetes

  year unknowncites this paper